Download Files:
Selnoflast
SKU
HY-132831-10 mg
Category Reference compound
Tags Immunology/Inflammation, Inflammation/Immunology, NOD-like Receptor (NLR)
$390 – $3,300
Products Details
Product Description
– Selnoflast (example 6) is a NLRP3 inhibitor (extracted from patent WO2019008025)[1].
Web ID
– HY-132831
Storage Temperature
– -20°C, 3 years (Powder)
Shipping
– Blue Ice
Applications
– COVID-19-immunoregulation
Molecular Formula
– C20H29N3O3S
References
– [1]Cooper, Matthew, et al. Novel sulfonamidocarboxamide compounds as NLRP3 inhibitors and their preparation. Patent. WO2019008025.
CAS Number
– 2260969-36-4
Molecular Weight
– 391.53
Compound Purity
– 98.58
SMILES
– O=C(NS(=O)(C1CCN(CC1)CC)=O)NC2=C(CCC3)C3=CC4=C2CCC4
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 1M NaOH : 3.33 mg/mL (adjust pH to 12 with 1M NaOH)|DMSO : 5 mg/mL (ultrasonic;adjust pH to 8 with 1M NaOH)
Target
– NOD-like Receptor (NLR)
Isoform
– NLRP3
Pathway
– Immunology/Inflammation
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.